Free Trial

Keurig Dr Pepper (KDP) Stock Forecast & Price Target

Keurig Dr Pepper logo
$32.65 -0.20 (-0.61%)
(As of 06:04 PM ET)

Keurig Dr Pepper - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
8

Based on 15 Wall Street analysts who have issued ratings for Keurig Dr Pepper in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 7 have given a hold rating, and 8 have given a buy rating for KDP.

Consensus Price Target

$38.36
17.48% Upside
According to the 15 analysts' twelve-month price targets for Keurig Dr Pepper, the average price target is $38.36. The highest price target for KDP is $42.00, while the lowest price target for KDP is $34.00. The average price target represents a forecasted upside of 17.48% from the current price of $32.65.
Get the Latest News and Ratings for KDP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Keurig Dr Pepper and its competitors.

Sign Up

KDP Analyst Ratings Over Time

TypeCurrent Forecast
11/27/23 to 11/26/24
1 Month Ago
10/28/23 to 10/27/24
3 Months Ago
8/29/23 to 8/28/24
1 Year Ago
11/27/22 to 11/27/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$38.36$38.50$36.50$37.20
Forecasted Upside17.48% Upside11.34% Upside0.77% Upside14.29% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

KDP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KDP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Keurig Dr Pepper Stock vs. The Competition

TypeKeurig Dr PepperConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.53
2.49
2.50
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside17.26% Upside36.37% Upside6.81% Upside
News Sentiment Rating
Positive News

See Recent KDP News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/28/2024Barclays
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$41.00 ➝ $39.00+12.81%
10/25/2024Citigroup
3 of 5 stars
F. Falorni
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$43.00 ➝ $40.00+15.44%
10/25/2024Jefferies Financial Group
2 of 5 stars
 Lower TargetBuy ➝ Buy$42.00 ➝ $41.00+17.41%
10/25/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$41.00 ➝ $42.00+20.27%
10/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$41.00 ➝ $40.00+14.38%
10/25/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$43.00 ➝ $42.00+20.21%
9/26/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$35.00 ➝ $40.00+6.84%
9/23/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$36.00 ➝ $37.00-1.49%
9/5/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ottenstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$36.00+4.71%
6/17/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold$27.00 ➝ $34.00-0.12%
6/10/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$39.00 ➝ $40.00+17.37%
2/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$37.00 ➝ $34.00+15.10%
2/26/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$37.00 ➝ $35.00+17.53%
12/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$37.00+13.78%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$40.00 ➝ $37.00+26.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:40 PM ET.


Should I Buy Keurig Dr Pepper Stock? KDP Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 22, 2024. Please send any questions or comments about these Keurig Dr Pepper pros and cons to contact@marketbeat.com.

Keurig Dr Pepper
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Keurig Dr Pepper Inc.:

  • The company recently increased its quarterly dividend from $0.22 to $0.23 per share, reflecting a commitment to returning value to shareholders. This represents an annualized dividend yield of 2.80%, which can be attractive for income-focused investors.
  • Keurig Dr Pepper Inc. has shown resilience with a quarterly revenue increase of 2.3% compared to the same quarter last year, indicating steady demand for its products.
  • The stock is currently trading at $33.15, which may present a buying opportunity for investors looking for growth potential, especially given the consensus target price of $38.36.
  • Analysts have a consensus rating of "Moderate Buy" for the stock, with several firms recently adjusting their price targets favorably, suggesting positive market sentiment.
  • Institutional ownership is strong, with hedge funds and other institutional investors holding 85.23% of the company's stock, which can indicate confidence in the company's future performance.

Keurig Dr Pepper
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Keurig Dr Pepper Inc. for these reasons:

  • The stock has experienced volatility, recently trading down 2.9% to $32.88, which may raise concerns about short-term performance and market sentiment.
  • Despite a slight revenue increase, the company reported earnings that met analysts' expectations but did not exceed them, which could indicate a lack of strong growth momentum.
  • The current ratio of 0.51 suggests that the company may have liquidity issues, as it indicates that current liabilities exceed current assets, potentially impacting its ability to cover short-term obligations.
  • With a debt-to-equity ratio of 0.50, the company has a moderate level of debt, which could pose risks if interest rates rise or if the company faces operational challenges.
  • Recent insider selling, including a major shareholder selling 69 million shares, could signal a lack of confidence in the company's future prospects, which may concern potential investors.

KDP Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Keurig Dr Pepper is $38.36, with a high forecast of $42.00 and a low forecast of $34.00.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Keurig Dr Pepper in the last twelve months. There are currently 7 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" KDP shares.

According to analysts, Keurig Dr Pepper's stock has a predicted upside of 17.48% based on their 12-month stock forecasts.

Over the previous 90 days, Keurig Dr Pepper's stock had 2 upgrades by analysts.

Analysts like Keurig Dr Pepper more than other "consumer staples" companies. The consensus rating for Keurig Dr Pepper is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how KDP compares to other companies.


This page (NASDAQ:KDP) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners